Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Hybrid Revascularisation by Combined CABG and PCI in Multivessel Coronary Disease. An Observational Study.

NCT01443754 is registered in ClinicalTrials.gov with Ettore Sansavini Health Science Foundation as lead sponsor.

NCT NCT01443754
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01443754 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Hybrid Revascularisation by Combined CABG and PCI in Multivessel Coronary Disease. An Observational Study.
Lead sponsor
Ettore Sansavini Health Science Foundation
Phase
Observational
Overall status
Terminated
Start date
September 30, 2011
Completion date
April 30, 2016
Enrollment
50 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

coronary artery disease (cad)